Abstract
The present study was undertaken to explore the relationship of plasma homocysteine with other biochemical parameters in ischemic heart disease. Plasma levels of total homocysteine was measured by HPLC—fluorescence detection with internal standard in 60 ischemic heart disease patients and were compared with 30 age matched normal healthy controls. The significant increase of plasma homocysteine was observed in both myocardial infarction and chronic stable ischemic heart disease patients when compared with the controls. The hyperhomocysteinemia appears be to due to increased body demand of vitamins such as folic acid, vitamin B12, B6, B2 either alone or in combination to regulate normal homocysteine metabolism.
Keywords: Ischemic heart disease (IHD), High density lipoprotein (HDL), High performance liquid chromatography (HPLC), Homocysteine (Hcy), Total cholesterol (TC) and Triglycerides (TG)
Full Text
The Full Text of this article is available as a PDF (80.3 KB).
References
- 1.Graham I.M., Daly L.E., Refsum H.M. Plasma homocysteine as risk factor for vascular disease. The European Concerted Action Project. J. Am. Med. Assocn. 1997;277:1775–1781. doi: 10.1001/jama.277.22.1775. [DOI] [PubMed] [Google Scholar]
- 2.Wald N.J., Walt H.C., Law M.R., Weir D.G., Partlin J., Scott J.M. Homocysteine and ischemic heart disease. Arch. Int. Med. 1998;158:862–867. doi: 10.1001/archinte.158.8.862. [DOI] [PubMed] [Google Scholar]
- 3.Sathia G., Lalitha S. Homocysteine and cardiovascular disease. Ind. J. Clin. Practice. 2000;11/6:59–65. [Google Scholar]
- 4.Welch G., Loscalzo J. Homocysteine and atherothrombosis. N. Eng. J. Med. 1998;338/15:1042–1050. doi: 10.1056/NEJM199804093381507. [DOI] [PubMed] [Google Scholar]
- 5.Chambers J.C., Obeid O.A., Refsum H. Plasma homocysteine concentrations and risk of coronary heart disease in UK, Indian Asians and European men. Lancet. 2000;355:523–527. doi: 10.1016/S0140-6736(99)93019-2. [DOI] [PubMed] [Google Scholar]
- 6.Singh M. A case of acute myocardial infarction associated with hyperhomocysteinemia. J. Ind. Acad. Clin. Med. 2000;3/3:317–318. [Google Scholar]
- 7.Ueland P., Refsum H., Stabler S., Malinow M., Andresson A., Allen R. Total homocysteine in plasma or serum: Methods and clinical applications. Clin. Chem. 1993;39/9:1764–1779. [PubMed] [Google Scholar]
- 8.Schreiner R., Gobel-Schreiner B., Walch S. Homocysteine: Biochemie and Klinische Bedeutung. Clinical Laboratory. 1995;41:1007–1011. [Google Scholar]
- 9.Silkers K.A., Crit C.R.C. Estimation of serum total cholesterol by enzymatic method. Rev. Clin. Lab. Sci. 1997;8:198–198. [Google Scholar]
- 10.Richmond W. Estimation of serum HDL-cholesterol. Clin. Chem. 1973;19:1350–1350. [PubMed] [Google Scholar]
- 11.Buccola G., David M. Estimation of serum triglycerides. Clin. Chem. 1973;19:476–476. [PubMed] [Google Scholar]
- 12.Neely M.D. Folic acid. In: Presce A.J., Kaplan L.A., editors. Methods in clinical laboratory. St. Louis: CV Mosby; 1987. [Google Scholar]
- 13.Chen J.W., Sperling M.I., Heminger L.A. Vitamin B12. In: Presce A.J., Kaplan L.A., editors. Methods in clinical laboratory. St. Louis: CV Mosby; 1987. pp. 569–573. [Google Scholar]
- 14.Kei Satoh. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica. Chimica. Acta. 1978;90:37–43. doi: 10.1016/0009-8981(78)90081-5. [DOI] [PubMed] [Google Scholar]
- 15.Cholesterol guidelines A call for more aggressive lipid lowering. Current Medical Scene. 2001;16/3:1–1. [Google Scholar]
- 16.Israelsson B., Brattstrom L.E., Hultberg B.E. Homocysteine and myocardial infarction. Atherosclerosis. 1988;71:227–233. doi: 10.1016/0021-9150(88)90147-5. [DOI] [PubMed] [Google Scholar]
- 17.Bree A., Verschuren W.M.M., Kromhout D., Klujtmans L.A.J., Blom H.J. Homocysteine determinants and the evidence to what extent homocysteine determine the risk of coronary heart disease. Pharmacol. Rev. 2002;54/4:599–618. doi: 10.1124/pr.54.4.599. [DOI] [PubMed] [Google Scholar]